Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 636

1.

Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).

Meier JJ, Deifuss S, Klamann A, Schmiegel W, Nauck MA; LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).

Exp Clin Endocrinol Diabetes. 2003 Sep;111(6):344-50.

PMID:
14520601
2.

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A, Holmes DR Jr.

J Am Coll Cardiol. 1999 Jan;33(1):119-24.

3.

Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide)

Klamann A, Sarfert P, Launhardt V, Schulte G, Schmiegel WH, Nauck MA.

Eur Heart J. 2000 Feb;21(3):220-9.

PMID:
10639304
4.

Role of previous treatment with sulfonylureas in diabetic patients with acute myocardial infarction: results from a nationwide French registry.

Danchin N, Charpentier G, Ledru F, Vaur L, Guéret P, Hanania G, Blanchard D, Lablanche JM, Genès N, Cambou JP.

Diabetes Metab Res Rev. 2005 Mar-Apr;21(2):143-9.

PMID:
15386810
5.

Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project).

Berger AK, Breall JA, Gersh BJ, Johnson AE, Oetgen WJ, Marciniak TA, Schulman KA.

Am J Cardiol. 2001 Feb 1;87(3):272-7.

PMID:
11165959
7.

Relationship between antidiabetic treatment with QT dispersion during acute coronary syndromes in type 2 diabetes: comparison between patients receiving sulfonylureas and insulin.

Tentolouris N, Matsagura M, Psallas M, Chatzizacharias A, Fotia M, Arvanitis M, Katsilambros N.

Exp Clin Endocrinol Diabetes. 2005 May;113(5):298-301.

PMID:
15926117
8.

Arrhythmias and mortality after myocardial infarction in diabetic patients. Relationship to diabetes treatment.

Davis TM, Parsons RW, Broadhurst RJ, Hobbs MS, Jamrozik K.

Diabetes Care. 1998 Apr;21(4):637-40.

PMID:
9571356
9.

The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

Mellbin LG, Malmberg K, Norhammar A, Wedel H, Rydén L; DIGAMI 2 Investigators.

Eur Heart J. 2008 Jan;29(2):166-76. Epub 2007 Dec 21.

PMID:
18156614
10.

Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group.

Gustafsson I, Hildebrandt P, Seibaek M, Melchior T, Torp-Pedersen C, Køber L, Kaiser-Nielsen P.

Eur Heart J. 2000 Dec;21(23):1937-43.

PMID:
11071799
11.

Prognostic value of admission plasma glucose and HbA in acute myocardial infarction.

Hadjadj S, Coisne D, Mauco G, Ragot S, Duengler F, Sosner P, Torremocha F, Herpin D, Marechaud R.

Diabet Med. 2004 Apr;21(4):305-10.

PMID:
15049930
12.

Management and short-term outcome of diabetic patients hospitalized for acute myocardial infarction: results of a nationwide French survey.

Vaur L, Danchin N, Hanania G, Cambou JP, Lablanche JM, Blanchard D, Clerson P, Gueret P.

Diabetes Metab. 2003 Jun;29(3):241-9.

PMID:
12909812
13.

Long-term glycemic control relates to mortality in type II diabetes.

Andersson DK, Svärdsudd K.

Diabetes Care. 1995 Dec;18(12):1534-43.

PMID:
8722048
14.

Sulfonylureas and mortality in diabetic patients after myocardial infarction.

Brady PA, Al-Suwaidi J, Kopecky SL, Terzic A.

Circulation. 1998 Feb 24;97(7):709-10. No abstract available.

15.

[Influence of impaired glucose tolerance on long-term survival after acute myocardial infarction].

Meier JJ, Deifuss S, Gallwitz B, Klamann A, Schmiegel W, Nauck MA.

Dtsch Med Wochenschr. 2002 May 24;127(21):1123-9. German.

PMID:
12085306
16.

QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction.

Sakabe K, Fukuda N, Fukuda Y, Wakayama K, Nada T, Morishita S, Shinohara H, Tamura Y.

Nutr Metab Cardiovasc Dis. 2008 Feb;18(2):121-6. Epub 2007 Mar 7.

PMID:
17346952
17.

[Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].

Gustafsson I, Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt PR, MacLeod K, Laakso M, Torp-Pedersen CT, Waldenström A; DIGAMI-2 investigatorerne.

Ugeskr Laeger. 2006 Feb 6;168(6):581-4. Danish.

PMID:
16476220
18.

Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.

Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenström A; DIGAMI 2 Investigators.

Eur Heart J. 2005 Apr;26(7):650-61. Epub 2005 Feb 23.

PMID:
15728645
19.

Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction.

Norhammar A, Malmberg K, Rydén L, Tornvall P, Stenestrand U, Wallentin L; Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA).

Eur Heart J. 2003 May;24(9):838-44.

PMID:
12727151
20.

Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.

Sosnowski C, Janeczko-Sosnowska E, Woźniak J, Jasiński B, Dabrowski R, Sumiński A, Wiernikowski A, Ostrzycki A, Szwed H, Ruzyłło W.

Kardiol Pol. 2007 Oct;65(10):1181-6; discussion 1187-9. English, Polish.

Supplemental Content

Support Center